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Treatment Efficacy of Intermittent Claudication by Surgical Intervention,
Supervised Physical Exercise Training Compared to No Treatment in
Unselected Randomised Patients I: One Year Results of Functional and
Physiological Improvements
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Objectives: to compare the effect of surgery, exercise and simple observation on maximum exercise power in claudicants.
Design: prospective, randomised study.
Methods: a total of 264 unselected claudicants were randomised to supervised exercise training, invasive treatment (open
surgical or endovascular procedures) or observation. One year treatment outcomes were analysed on an intention to-treat
basis.
Results: invasively treated patients showed a significant improvement in maximum walking power, stopping distance,
post-ischaemic blood flow and big toe pressure at one year. Patients randomised to physical exercise training or to the
control group did not improve in any outcome measure.
Conclusion: invasive treatment increased walking capacity, leg blood pressure and flow. Supervised physical exercise
training offered no therapeutic advantage compared to untreated controls.
Key Words: Randomised; Intermittent claudication; Exercise; Quality of life; Treadmill.
Introduction Methods
The management of intermittent claudication (IC) is Patients presenting intermittent claudication were re-
ferred to the vascular surgical outpatient clinic atcontroversial and randomised controlled data is
sparse.1–19 Traditionally, treatment consists of modi- Sahlgrenska University Hospital, Go¨teborg, Sweden.
All patients were willing to undergo angiography andfication of risk factors, and exercise training.9 Re-
constructive surgery is not widely applied, possibly subsequent operations when offered participation.
because the restriction to patients’ lifestyle has not
been considered severe enough to justify the risks.13
We previously reported that postoperative physical Study design
exercise improved walking ability more so than oper-
ation alone.20 The aim of the present study was there- Patients were randomised into one of three groups:
fore to evaluate supervised physical exercise training control, supervised physical exercise training, or in-
and invasive therapy versus observation (no treat- vasive treatment. Patients randomised to the control
ment) in patients with IC at one year follow-up. In a or training groups were allowed to change group
companion paper we also evaluate the impact of the to invasive therapy if requested, provided that their
different options on quality of life. symptoms deteriorated towards severe ischaemia dur-
ing the course of follow up. All patients were, however,
analysed on an intention to-treat basis. Sample size
was estimated to include a cohort of patients sufficient
∗ Please address all correspondence to: K. Lundholm, Department in number to allow assessment of treatment outcomeof Surgery, Sahlgrenska University Hospital, SE 413 45 Go¨teborg,
Sweden. of at least 80 patients in each allocated group at one
1078–5884/01/080107+07 $35.00/0  2001 Harcourt Publishers Ltd.
J. Gelin et al.108
year of follow-up based on the experience and power walking capacity was expressed in watts and the max-
imum walking distance in meters.22,23 Standard calfcalculations according to the results in our previous
interventional studies with three groups, where stat- blood flow measurements were assessed as maximum
post-ischaemic calf blood flow by occlusion ple-istically significant results among 75 randomised
patients were obtained.20 thysmography before treadmill walking.23 Big toe sys-
tolic pressure was measured using a plethysmography
technique. Ankle/brachial pressure measurements
Inclusion criteria were determined by standard sphygomanometer
where ankle pressure was measured with the aid of a
All patients with stable IC for more than 6 months handheld doppler probe.
were evaluated for inclusion. They should have an
ankle/brachial index <0.6 and a maximal post-isch-
aemic calf blood flow <25 ml/min/100 g to be eligible
Blood chemistryfor the study. Patients with a medical history con-
traindicating surgery and/or with other disorders se-
Standard laboratory analyses at Sahlgrenska Uni-verely limiting walking evaluation on a treadmill were
versity Hospital, Go¨teborg, Sweden were performedexcluded. A total of 264 unselected patients were
to determine levels of haemoglobin, serum creatinine,included in the study. These patients were randomly
cholesterol and triglycerides.recruited from a regional cohort of 400–500 patients
between 1994–1997.
Follow-upRandomisation
After randomisation, the patients were seen at thePatients were sequentially randomised according to a
outpatient clinic and explained the treatment al-procedure proposed by Pocock and Simon21 into three
location. The first follow-up visit at 6 months aftergroups, utilising a computer based mathematical algo-
randomisation assessed the clinical status of therithm, taking 21 assumed long-term prognostic vari-
patient. The main objective was to monitor any changesables into account. This procedure was deemed
in ischaemic symptoms and to evaluate patient andnecessary since a by chance skewness in assignment
study protocol adherence. The invasive group wascould bias interpretations and outcome conclusions.
also called to a postoperative visit 1 month after inter-The randomisation was performed by an independent
ventional therapy. One year after randomisation, thenurse, who communicated the allocation group to the
patients’ physical status, blood chemistry, pressure andresponsible physician. Demographic variables in-
physiological values and health status (see companioncluded age, gender, weight, height, smoking habits,
paper) were reassessed.presence or absence of diabetes mellitus. Blood chem-
istry variables were serum creatinine, cholesterol,
triglycerides and haemoglobin values. Pressure meas-
urements included systemic arterial blood pressure,
Treatment Groupssystolic ankle pressure and big toe systolic pressure.
Physiological testing parameters for stratification were
All patients were advised to give up smoking andresults of exercise ECG, dynamic spirometry, treadmill
our regular clinical recommendations for risk factorwalking test, and occlusion plethysmography values
management were followed.24,25 Planned interventionsbefore and after exercise. Further, presence or absence
started within 6 weeks following assignment to theof groin pulses, duration of symptoms, source of in-
study groups.come and dependency of domicilary help were in-
cluded in the stratification procedure.
Control group
Control patients received no other specific advice or
treatment apart from the general advice given to thePhysiological measurements
two treatment groups. Six patients could not adhere
to the control group as the presenting claudicatingThe walking test was performed on a treadmill with
a progressively inclinating slope from 0° to 12° sim- symptoms worsened to such a degree that they de-
manded invasive therapy.ulating a gradually increasing work load. Treadmill
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Table 1. Invasive treatment group: Surgical procedures, patency Table 2. Compliance to treatment allocation of 225 patients at-
tending evaluation 1 year after randomisation.rates and compliance, n=76.
Type of procedure No of Patency at Control Training Intervention
76 73 76procedure 1 year (%)
Total number of interventions 61 82 Requested change to 6∗ 9∗ NA
invasive treatmentAorto/iliaco-femoral by-pass 18 18/18 Unable or unwilling to NA 21 15#Endarterectomy (EA) of aorta/iliaca 2 2/2 complete allocatedIliaca angioplasty 6 3/6 treatmentAxillo-femoral by-pass 1 1/1 Completed treatment as 70 43 61Procedures above inguinal ligament, 27 24/27 (89%) allocatedtotal
EA±patch femoral artery/ 2 1/2 ∗Changed group due to deterioration of symptoms.
# Did not complete allocated treatment on technical or medicalprofundaplasty
Angioplasty superficial femoral 11 7/11 grounds. For further details, see Table 5.
NA: not applicable.artery
Femoro-popliteal synthetic by-pass 11 9/11 Table 3. Fate of randomised patients during first year of allocatedabove knee treatment.Femoro-popliteal vein by-pass 4 3/4
above knee Control Training InterventionFemoro-popliteal vein by-pass 4 4/4 89 88 87below knee
Distal vein by-pass 2 2/2 Attrition during first 13 15 11Procedures below inguinal 34 26/34 (76%) year of follow-upligament, total
Causes for attrition:
Death 4 5 5
Amputated 2 0 1Supervised physical exercise group
Lost to follow-up 5 7 3
Patients randomised to supervised exercise training Disabling intercurrent 1 2 2
disease prohibitingclasses were referred by the responsible physician (A-
follow-up∗G D) to specially designed physical training classes
Misdiagnosis# 1 1 0
under the supervision of trained physiotherapists. The
∗Disabling stroke, severe Parkinson’s disease, senility, hip arthrosis.training program consisted of three 30 min sessions of
# Spinal stenosis.specific walking training per week during the initial
6 months with 10–12 patients participating in each to provide for an optimal run-off. Altogether there
training class as described.15 After 6 months two were four reconstructions below the knee and two
sessions per week were offered.16 In addition to patients received crural by-passes, although by-pass
supervised training, patients were encouraged to un- to less than optimal crural arteries was rejected in two
dertake individual training programs. During the cases.
formal course of their training some patients opted Four cases of planned intervention were abandoned
for individualised program that accommodated their intraoperatively due to: popliteal artery inadequate
specific needs. (2), vein inadequate (1), incongruent operative findings
vs angiography (1). Eleven patients were never taken
to the operative theatre due to: extensive cardiac riskInvasive treatment group
Patients randomised to invasive therapy were referred (3), patient declined operative treatment (3), contrast
allergy (2), normal angiography (1), angiographicfor standard angiography. Based on the angiographic
findings, the appropriate intervention, either an en- findings not suitable (2).
Characteristics of the 264 randomised patients aredovascular or open surgical procedure was determined
according to current surgical management policy. A summarised in Table 4. The three groups did not differ
on any inclusion parameter at baseline demonstratingvariety of surgical procedures were performed, and a
total of 15 randomised patients (17%) were considered the power of the algorithm for stratification. A total
of 225 of 264 patients were followed up at 1 year,unsuitable for invasive therapy (Table 1). Patients with
stenoses and/or short occlusions Ζ3 cm of the iliac while two patients experienced 10–12 months follow-
up, but are included. Of the 39 patients not completingarteries and femoral artery stenoses and occlusion
Ζ5 cm were usually deemed suitable for endovascular 1 year follow-up, 14 had died, 15 were lost to follow-
up, 3 underwent amputation and 5 were unable totreatment. The choice of open surgical operations was
made in accordance with our clinical practice. All vein participate in follow-up visits due to disabling inter-
current disease. The number of patients lost to follow-grafts were utilised with the in-situ technique and if
judged necessary, the grafts were taken below the knee up were similar in the three groups (Tables 2, 3) as
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Table 4. Characteristics of 264 unselected patients with intermittent Results
claudication at randomisation. Values are given as mean±SD
when applicable.
Mortality compliance, amputation and patency
Control Training Intervention
89 88 87 The mortality rate did not differ among study and
Age, years (range) 67 (47–81) 67 (45–81) 66 (38–80) control patients, and the mortality rate (5.6%) and the
Gender male/female % 67/33 66/34 64/36 amputation rate (2.2%) in the control group was similar
Weight, kg 74.1±13.7 70.1±11.8 73.5±11.3 to the natural course for patients with intermittentHeight, m 1.70±0.08 1.69±0.08 1.70±0.09
Smoking habits, % 49/34/17 53/34/12 52/36/12 claudication known from epidemiological data in the
yes/ex-smoker/no literature.12
Diabetes, % 16 14 19 Of 73 patients examinable at 1 year, nine patientsSystolic blood pressure∗ 150±24 154±22 155±24
Ankle pressure∗ 84±19 86±20 85±17 in the exercise group underwent interventional ther-
Ankle/brachial index 0.56 0.56 0.55 apy due to worsening of symptoms. These patients
Systolic big toe 53±17 55±22 54±19 had significantly lower values than the other patientspressure∗
Maximum exercise 94±38 89±35 91±44 in the cohort allocated to this group on treadmill
power, Watts performance testing and maximum walking distance
Maximum treadmill 272±153 258±142 274±172 (73 vs 89 Watt and 193 vs 258 m respectively), post-walking distance, metres
Maximum post- 13.3±6.1 13.1±8.5 13.5±7.9 ischaemic flow measurements (7 vs 13 ml/min/100 g)
ischaemic calf blood and toe pressure measurements (42 vs 55 mmHg). Of
flow, ml/min/100 g the remaining 64 patients, 21 were unwilling or unableHaemoglobin 146±11 147±12 144±13
(132–166)∗∗ g l−1 to complete the prescribed training program for a
Cholesterol (2.3–8.5)∗∗ 7.0±1.9 6.9±1.5 6.6±1.4 number of reasons. The most frequent cause was that
mol l−1 after attending a few classes patients were unable toTriglycerides (0.5–1.6)∗∗ 2.1±1.0 2.2±1.2 2.1±1.0
mol l−1 keep up with proposed training schedule. Hence, 43
Creatinine (60–120)∗∗ 103±24 99±23 103±26 of 73 (59%) patients finalised their exercise program
mol l−1 as prescribed.
∗mmHg. At 1 year follow-up, 89% of supra-inguinal re-
∗∗Values within parentheses normal reference values. constructions were patent (24 out of 27), whereas only
76% (26 of 34) of infra-inguinal reconstructions were
the causes of attrition during the first year of follow- judged patent on clinical assessment with pulse palp-
up. ation and handheld doppler examination. Femoral
pulse quality on palpation in patients with completed
Ethics 1 year follow-up was normal in 47% of controls, 52%
Informed consent was obtained from all patients. The of exercised patients and in 41% of surgical patients,
study protocol was approved by the Ethics Committee and was reduced/absent in 53%, 48% and 59% re-
of the Medical Faculty, Go¨teborg University, Sweden. spectively. Failures in patency were mainly found in
the superficial femoral artery segment treated either
Statistical methods by endovascular intervention or by synthetic grafts
Patients were only analysed on an intention-to-treat placed in the above knee position. All vein grafts
basis (Tables 2, 3). This means that the six patients placed above or below knee and all distal by-passes
randomised to the control group and nine patients in were patent except one case.
the training group, who were subsequently operated
upon remained in their original groups during follow-
up analyses. Standard descriptive parametric statistics Physiological results (Table 5, Figs 1–3)
are mean±SD. Between-group comparisons were per-
formed at 1 year follow-up by the non-parametric At 1 year follow-up, significant improvement was
found for physiological parameters in the invasivelyKruskal–Wallis analysis of variance. p values of less
than 0.05 are indicated as statistically significant, but treated group only. Hence, treadmill exercise power
(Fig. 1) maximum treadmill walking distance, max-p<0.01 was deemed necessary for a statistically sig-
nificant out-fall due to the large number of min- imum post-ischaemic calf blood flow following tread-
mill exercise (Fig. 2) and big toe systolic pressure (Fig.imisation factor in the randomisation assignment and
to reduce the risk for multiple comparison significance. 3) improved, as did ankle-brachial index (ABI-Table
5). No improvement in these parameters occurred inMaximum exercise power in watts was the primary
end point variable in this study. the training or control group.
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Table 5. Characteristics and results on intention-to-treat basis of
225 randomised patients at 1 year follow-up. Results are given as
mean±SD when applicable.
Control Training Intervention
76 73 76
Systolic blood pressure 154±29 158±28 161±35
mmHg
Ankle/brachial index 0.53 0.54 0.71∗
Maximum treadmill 261±131 247±111 344±169∗
walking distance, metres
Haemoglobin (132–166)† 144±12 140±21 140±14
g l−1
Cholesterol (2.3–8.5)† 6.4±1.6 6.6±1.4 6.5±1.2
mol l−1
Triglycerides (0.5–1.6)† 2.0±1.1 1.9±1.2 2.1±1.4
mol l−1
Creatinine (60–120)† 102±32 102±25 107±36
mol l−1
∗Denotes statistically significant difference. p<0.01. Fig. 2. Maximum post-ischaemic calf blood flow before ran-
† Values within parentheses normal reference values. domisation and at 1 year of follow-up. A significant between group
difference was noted at 1 year follow-up. ∗∗ p<0.001.
Fig. 1. Maximum exercise power (watt) in treadmill walking before
randomisation and at 1 year follow-up. A significant between group Fig. 3. Systolic big toe pressure before randomisation and at 1 year
difference was noted at 1 year follow-up. ∗∗ p<0.002. of follow-up. A significant between group difference was observed
at 1 year follow-up. ∗∗ p<0.001.
Discussion
their dominant presenting symptom. Our results do
not support an old notion that a failed surgical pro-Claudication is considered a life-style limiting con-
dition rather than a threat to life or limb. The limitation cedure might compromise the claudicants’ prospect
of a later viable limb. Loss of life or limb in thein walking ability, assessed by treadmill, shows IC
patients to be disadvantaged to a similar degree as entire cohort of patients was similar among the three
treatment groups without difference to the naturalpatients with angina pectoris recommended coronary
arterial by-pass surgery.25 Thus, treatment strategies course of the disease known from epidemiological
surveys.12 The comparatively large number of “crossin claudication aim primarily at symptomatic relief.
Treatment options, apart from reduction of risk factors, overs” following the initial assignments do not limit
our conclusions, since surgical intervention (the finalare invasive therapy, exercise training and phar-
macological treatment.9,16,24 However, there is no re- treatment option) appeared to be the most effective
therapy. Thus, falsely improved outcome in the ob-ported treatment for IC with scientifically proven
efficacy in unselected groups of claudication patients.26 servational and physical exercise group did not appear
following evaluation by intention to treat.Patients enrolled in the present trial were therefore
consecutively referred to the vascular clinic for IC as A number of studies on exercise therapy report
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significant improvements in walking distances.9,15,16 limb circulation. Based on the angiography, patients
were either referred to the radiology department forHowever, the reasons for improvements have usually
endovascular treatment if the lesions were found toremained unexplained as most studies fail to dem-
be suitable for angioplasty, or to open surgery.onstrate any improvement in blood flow or ankle
In conclusion, only invasive therapy (surgery orpressure, although widening of the femoral A-V oxy-
angioplasty) improved circulation in unselectedgen content may occur. Factors like improved general
patients with intermittent claudication to an extent,well-being, blood rheology and muscular enzymatic
which led to functional improvement in walking abilityoxidative capacity have been suggested for improved
and maximum exercise power. Improvement in cir-pain-free walking distance.18 Although studies on su-
culatory parameters like big toe pressure and post-pervised physical exercise training support its benefit,
exercise maximum calf blood flow values supportedthe evidence is based on either uncontrolled or small
the functionally based improvements. Conservativerandomised studies in selected groups of patients.20 A
applications (supervised training, observation) had norecent meta-analysis9 on exercise programs concluded
such impact. The results in the exercise group did notthat the greatest improvement in walking distance was
differ from the results in the observational controlachieved with supervised programs lasting 30 min
group. One explanation for this unexpected outcomethree times a week for at least 6 months. Information
may be that compliance to training programs is toowas not supplied regarding how long the effects of
low in unselected groups of patients with vascularexercise benefited the patients, treatment costs or com-
disease. Another explanation may be that regular ex-pliance to physical training. Furthermore, no attempt
ercise is actually ineffective in a majority of patientswas made to translate a statistically significant im-
with progressive intermittent claudication. A hesitanceprovement in metres to clinically meaningful im-
to a comparatively short observation time for ourplications,27 which was included in our present
patients is limited, since there is no reason to believeprotocol with quality of life evaluations.
that effects of training should appear beyond 1 yearSeveral studies have addressed the issue of
only, although the overall effect of surgical interventionincreasing use of angioplasty for the treatment of
may vanish after 1 year. If so, both physical trainingclaudication.7,28–32 The threshold to recommend
and surgery would be of little use in treatment ofinterventional therapy is largely dependent on avail-
intermittent claudication. Thus, conservative physicalability and resources. All previous publications on
training may be regarded inefficient for a majority oftreatment outcome of IC applying endovascular/op-
patients with intermittent claudication, although iterative procedures or physical training have again
may be beneficial in selected individuals, probablyfocused on selected patients, suitable for the proposed with stable disease.
treatment. Our present study differs since an un-
selected cohort of patients was randomised to one of
three options before any pre-treatment investigation
had been carried out. In this way we were able to Acknowledgements
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